Erector Spinae Plane Block v.s Patient Controlled Analgesia in Correction Surgery for Idiopathic Scoliosis
Launched by WEST CHINA HOSPITAL · Dec 6, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of managing pain after scoliosis correction surgery, which is a procedure to straighten the spine. The researchers want to find out if a method called the Erector Spinae Plane Block (ESPB) can provide better pain relief than a common pain management technique called Patient Controlled Analgesia (PCA), where patients control their own pain medication through an IV. The goal is to see if ESPB can help reduce pain after surgery and lower the amount of opioid medication needed, which can have side effects.
To participate in the study, you need to be at least 14 years old and scheduled for scoliosis surgery. You also need to give consent, either yourself or through a guardian. However, some people may not qualify, especially if they have allergies to certain medications or serious health issues. If you join the study, you will be randomly assigned to one of the two pain management methods, and the researchers will track your pain levels, medication use, and any side effects you may experience after the surgery. This trial is important as it aims to find a potentially safer and more effective way to manage pain in patients undergoing scoliosis surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 14 years or older, regardless of gender.
- • Scheduled for scoliosis correction surgery.
- • Signed informed consent from the participant or their legal guardian.
- Exclusion Criteria:
- • Allergy to local anesthetics such as ropivacaine.
- • Family history of malignant hyperthermia.
- • Severe systemic diseases affecting the heart, lungs, liver, or kidneys.
- • Neurological or psychiatric disorders.
- • Communication difficulties, such as hearing impairment or speech disorders.
- • Concurrent participation in other clinical studies.
- • Other conditions deemed unsuitable for participation by the investigators.
About West China Hospital
West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
Patients applied
Trial Officials
Ren Liao, M.D.
Principal Investigator
West China Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported